Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherShares Issued
Ratios

Theravance Biopharma (TBPH) Other Gross PP&E Adjustments (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Other Gross PP&E Adjustments for 13 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 215.75% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, up 215.75% year-over-year, with the annual reading at $2.2 million for FY2025, 215.75% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $2.2 million at Theravance Biopharma, up from -$25.4 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $12.5 million in Q4 2021, with the low at -$42.5 million in Q1 2021.
  • Average Other Gross PP&E Adjustments over 5 years is -$26.6 million, with a median of -$33.6 million recorded in 2024.
  • The sharpest move saw Other Gross PP&E Adjustments crashed 3259.58% in 2023, then surged 215.75% in 2025.
  • Over 5 years, Other Gross PP&E Adjustments stood at $12.5 million in 2021, then plummeted by 97.7% to $287000.0 in 2022, then plummeted by 3259.58% to -$9.1 million in 2023, then skyrocketed by 78.64% to -$1.9 million in 2024, then soared by 215.75% to $2.2 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $2.2 million, -$25.4 million, and -$26.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.